Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial

Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. This is a minor maintenance update that does not change study information.
    Difference
    0.0%
    Check dated 2026-03-12T00:28:26.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    New revision tag v3.4.2 appears and the site-wide funding notice was removed; no trial data or user actions were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T14:00:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations. Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), while removing earlier labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').
    Difference
    0.1%
    Check dated 2026-01-28T06:23:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study content or user-facing information appears to be changed.
    Difference
    0.0%
    Check dated 2026-01-14T03:07:22.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new 'Locations' section with state listings was added; individual state location subsections and the HHS Vulnerability Disclosure section were removed.
    Difference
    2%
    Check dated 2025-12-23T20:43:13.000Z thumbnail image

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.